Today: 7 February 2026
Subscribe
Browse Category

NYSE:TMO News 24 January 2026 - 6 February 2026

Thermo Fisher stock price today: TMO nudges higher after Thursday drop as investors eye next week’s data

Thermo Fisher stock price today: TMO nudges higher after Thursday drop as investors eye next week’s data

Thermo Fisher shares rose 0.6% to $545.58 Friday afternoon, recovering some ground after a 4% drop Thursday. The move lagged the broader market, with the S&P 500 up 1.73%. Investors remain cautious amid weak academic research funding and uncertain lab order trends. Upcoming U.S. jobs and inflation data could affect rate expectations and valuations.
6 February 2026
·····
Thermo Fisher stock keeps sliding after 2026 outlook — what to watch for TMO this week

Thermo Fisher stock keeps sliding after 2026 outlook — what to watch for TMO this week

Thermo Fisher shares fell 2.3% to $578.61 Friday, their fourth straight decline, after management warned of 2026 profit headwinds tied to U.S. research funding cuts. The stock closed about 10% below its 52-week high on heavy volume. Investors are watching Monday’s open for signs of continued selling. Peers Danaher and Waters also slipped.
1 February 2026
·····
Thermo Fisher Scientific stock price slides to $578.61 after 2026 outlook; what to watch Monday

Thermo Fisher Scientific stock price slides to $578.61 after 2026 outlook; what to watch Monday

Thermo Fisher Scientific shares fell 2.29% to $578.61 Friday, extending a four-day slide after issuing a cautious 2026 outlook and forecasting earnings below Wall Street’s average estimate. Volume reached 3.7 million shares, nearly double the daily average. The company cited continued pressure from frozen academic research grants. Fourth-quarter revenue rose 7% to $12.21 billion, with adjusted EPS at $6.57.
31 January 2026
·····
Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher shares edged up 0.1% to $219.83 Friday after steep losses earlier in the week. The company reported Q4 revenue of $6.84 billion and adjusted EPS of $2.23, with 2026 earnings guidance in line with analyst forecasts. Investors remain cautious amid weak academic research funding and recent stock swings. Vanguard disclosed an 8.63% stake in Danaher as of Dec. 31.
30 January 2026
········
Thermo Fisher stock slides on 2026 profit outlook as research funding cuts bite — what’s next for TMO

Thermo Fisher stock slides on 2026 profit outlook as research funding cuts bite — what’s next for TMO

Thermo Fisher shares fell 2.6% to $592.16 after the company forecast 2026 profits below Wall Street estimates, citing weaker U.S. academic research funding. The company projected adjusted earnings of $24.22 to $24.80 per share, missing consensus. Fourth-quarter revenue rose 7% to $12.21 billion, beating expectations. CFO Stephen Williamson will retire in March, with Jim Meyer named as successor.
30 January 2026
·····
Thermo Fisher (TMO) stock drops after 2026 profit outlook misses on research funding cuts

Thermo Fisher (TMO) stock drops after 2026 profit outlook misses on research funding cuts

Thermo Fisher shares fell 2.6% to $592.08 after the company forecast 2026 adjusted profit below Wall Street estimates, citing continued weakness in U.S. academic and government funding. The firm projected 2026 adjusted EPS of $24.22–$24.80 and revenue of $46.3–$47.2 billion. Fourth-quarter revenue rose 7% to $12.21 billion. Investors are watching the timing of the Clario acquisition, expected to close by mid-2026.
29 January 2026
·····
Thermo Fisher (TMO) stock slides into earnings — here’s what Wall Street is watching

Thermo Fisher (TMO) stock slides into earnings — here’s what Wall Street is watching

Thermo Fisher shares fell 2.55% to $608.02 Wednesday, their second straight decline ahead of Thursday’s Q4 earnings call. Trading volume topped 2.3 million, above average, as investors weighed Danaher’s warning on weak academic research funding. The stock now sits 5.6% below its Jan. 22 high. Life-science tools stocks broadly declined during the session.
29 January 2026
·····
Thermo Fisher Scientific stock rises toward $631 as TMO heads into Jan. 29 earnings

Thermo Fisher Scientific stock rises toward $631 as TMO heads into Jan. 29 earnings

Thermo Fisher shares rose 0.8% to $631.24 by midday Monday in New York, rebounding from an early dip ahead of Thursday’s earnings report and 2026 outlook. Options markets point to an expected 4% swing after results. Analysts forecast Q4 earnings of $6.43 per share, up from $6.10 a year ago. The company will hold its earnings call at 8:30 a.m. ET on Jan. 29.
26 January 2026
·····
Thermo Fisher (TMO) stock slips from fresh high as earnings week and Fed decision loom

Thermo Fisher (TMO) stock slips from fresh high as earnings week and Fed decision loom

Thermo Fisher shares fell 2.11% to $625.98 Friday, ending a three-day rally and closing 2.8% below Thursday’s 52-week high. The company reports earnings before the market opens Jan. 29, following Danaher’s results and the Fed’s Jan. 27-28 meeting. The S&P 500 health care index slipped 0.56% Friday. Analyst consensus expects Thermo Fisher to post $6.44 EPS on $11.95 billion revenue for the quarter.
25 January 2026
·····
Thermo Fisher (TMO) stock pulls back from a fresh high as Jan. 29 earnings loom

Thermo Fisher (TMO) stock pulls back from a fresh high as Jan. 29 earnings loom

Thermo Fisher Scientific shares fell 2.1% to $625.98 on Friday, reversing after a 52-week high the previous day. Trading volume was above average as investors positioned ahead of next week’s earnings and a Federal Reserve meeting. The company’s 1.400% senior notes due 2026 are being delisted from the NYSE. Thermo Fisher reports fourth-quarter results before markets open on Jan. 29.
24 January 2026
·····
Thermo Fisher stock slips from fresh high — what traders watch before earnings week

Thermo Fisher stock slips from fresh high — what traders watch before earnings week

Thermo Fisher Scientific shares fell 2.1% to $625.98 Friday, ending a three-day rally and retreating from a 52-week high. The drop came ahead of the company’s Jan. 29 earnings release and as peers Waters and Danaher also declined about 2%, signaling profit-taking in the life-sciences tools sector. Investors await updates on Thermo Fisher’s planned Clario acquisition and outlook for 2026.
24 January 2026
·····
1 2 3 … 5

Stock Market Today

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

7 February 2026
Ashtead shares closed Friday at 4,936p, up 1.09%, after the company bought 88,872 shares under its repurchase program. The group is set to shift its primary listing to New York on March 2, pending court approval, and will be removed from the FTSE UK index the same day. Ashtead paid a half-year dividend of 37.5 U.S. cents per share on Friday.
Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

7 February 2026
Beazley shares closed flat at 1,236 pence Friday as BlackRock disclosed a 6.55% stake and Vanguard reported 5.02%. Wellington Management cut its holding below 5%. The disclosures follow Zurich Insurance’s possible takeover offer of up to 1,335 pence per share, with a Feb. 16 deadline for a firm bid.
Go toTop